Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Lunargate on Stocktwits is an AI creation

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Jan 11, 2023 8:04pm

106 Views

Post# 35217214

RE:RE:RE:RE:Lunargate on Stocktwits is an AI creation

I has to write on a level u can comprandy. if ur worried about the spelling then its a slow day for oncy. I could resort to drawing u pics if that is easier for youins.

<< Previous

Bullboard Posts

Next >>

Bombardier partially redeems US$788 million in senior notes